DONGGUANG CHEM (01702) announced its interim results, with shareholders' profit attributable to shareholders of 112 million yuan, a 55% increase year-on-year.
Dongguang Chemical (01702) announced its results for the six months ending June 30, 2026. During this period, the group achieved revenue of 1.21 billion yuan, an increase of 2.5% year-on-year; the profit attributable to shareholders was 112 million yuan, a year-on-year increase of 55%; and the basic earnings per share were 18.1 cents.
DONGGUANG CHEM (01702) announced its performance for the six months ending June 30, 2026, with the group achieving a revenue of 1.21 billion yuan, an increase of 2.5% year-on-year; the profit attributable to shareholders was 112 million yuan, an increase of 55% year-on-year; the basic earnings per share were 18.1 cents.
Related Articles
TATA HEALTH (01255) issued a profit warning, expecting a mid-term loss attributable to shareholders of approximately HKD 12.399 million.
PLANETREE INT'L (00613) responded to the issue of concentrated shareholding, stating that the company is able to comply with the public shareholding requirements.
DRAGON RISE GP (06829) has entered into a blockchain agency agreement with a comprehensive blockchain service provider.
TATA HEALTH (01255) issued a profit warning, expecting a mid-term loss attributable to shareholders of approximately HKD 12.399 million.
PLANETREE INT'L (00613) responded to the issue of concentrated shareholding, stating that the company is able to comply with the public shareholding requirements.
DRAGON RISE GP (06829) has entered into a blockchain agency agreement with a comprehensive blockchain service provider.
RECOMMEND
